查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014825

顱內支架市場：2026-2032年全球市場預測（依產品類型、材料、塗層、適應症、最終用戶和通路分類）

Intracranial Stents Market by Product Type, Material, Coating, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，顱內支架市場價值將達到 10.3 億美元，到 2026 年將成長至 11.9 億美元，複合年成長率為 15.22%，到 2032 年將達到 28 億美元。

主要市場統計數據
基準年 2025 10.3億美元
預計年份：2026年 11.9億美元
預測年份 2032 28億美元
複合年成長率 (%) 15.22%

對顱內支架進行全面說明，涵蓋臨床需求、器械發展、法規環境以及臨床實施的實際考慮因素。

顱內支架是工程創新與急性神經血管治療的關鍵結合點，也是治療動脈瘤和顱內狹窄的重要工具。過去二十年來，器械設計師和介入神經放射學醫生不斷改進支架的結構、材料和植入技術，以提升其在蜿蜒的腦血管中的操控性，並促進長期的血管重塑。這項發展得益於與臨床回饋的持續對話、影像技術的進步以及製造能力的提升，每一次改進都力求在最大限度降低手術風險的同時，擴大可治療病變的範圍。

器械工程、臨床技術和商業性方法的重大變革正在重新定義顱內支架的開發和應用。

顱內支架領域正經歷一場變革，主要得益於技術突破和臨床實務的轉變。材料技術的進步，特別是鎳鈦合金和鈷鉻合金加工技術的進步，使得在保持徑向強度的同時，能夠製造出外形更小、輸送性能更佳的支架。同時，雷射切割和編織結構的改良也使得支架的選擇更貼合病變形態。除了這些技術進步之外，旨在抑制新生內膜增生和降低血管再阻塞風險的藥物釋放型表面處理的日益普及，也預示著生物活性植入的應用前景更加廣闊。

2025 年關稅變化將如何重塑整個顱內支架生態系統的供應鏈、採購方式、監管規劃和商業策略。

計劃於2025年實施的關稅徵收和貿易政策調整，正為全球供應鏈帶來顯著的複雜性，並對顱內支架的製造、採購和定價策略產生可衡量的下游影響。依賴國際供應網路取得關鍵原料、精密合金加工或專業契約製造的製造商，正面臨不斷上漲的進口總成本和更長的前置作業時間。這些壓力迫使一些相關人員重新評估其籌資策略，許多公司正在加快推進近岸外包、雙重採購和替代供應商認證計劃，以維持生產的連續性並應對投入成本的波動。

將設備架構、材料科學、塗層生物學、適應症、終端用戶需求和分銷策略整合到連貫的商業化路徑中的實用細分見解。

市場區隔揭示了臨床需求、技術創新和商業策略的交匯點，從而形成差異化的價值提案。根據產品類型，市場可分為球囊擴張型裝置和自擴張式結構。在自擴張式裝置中，編織設計和雷射切割設計在性能上存在差異，這會影響複雜解剖結構中的臨床選擇。球囊擴張型結構在需要精確部署和血管支架支撐的場合仍然適用，而自擴張編織設計通常在彎曲的腦血管中具有更優異的適應性和血流調節性能。

區域分析解釋了臨床能力、監管方法和製造生態系統的差異如何影響美洲、歐洲、中東和非洲以及亞太地區的設備採用。

區域趨勢對顱內支架的推廣、監管和生產策略有顯著影響，因此，深入了解這些區域差異對於有效規劃至關重要。在美洲，高度集中的神經血管專科中心和成熟的醫保報銷體係有利於先進器械平台的早期應用，同時，採購委員會也越來越要求提供明確的經濟價值證據，以補充臨床療效。因此，尋求在美洲市場發展的公司優先考慮嚴謹的臨床數據、上市後註冊研究以及與卓越中心網路的直接合作，以加速產品推廣並促進產品的迭代改進。

這讓我們得以深入了解企業策略，並專注於成熟企業、創新者和供應商如何利用臨床數據、製造夥伴關係和服務模式來獲得競爭優勢。

主要企業的趨勢揭示了市場領導和新興企業如何將技術能力轉化為競爭優勢。成熟的醫療設備製造商正將投資重點放在合金加工、支架成型和輸送系統的迭代改進上，同時透過註冊登記和隨機對照試驗來累積大量的臨床證據，以支持與保險公司的對話。這些公司通常會投資加強其全球培訓網路和內部第一線團隊的能力，以支援高度複雜的手術，並與大型醫療保健系統簽訂長期合約。

為領導者提供可操作的建議，以透過整合產品藍圖、供應鏈彈性、臨床證據和混合商業策略來加速部署。

產業領導者應制定協調一致的策略，將產品開發、臨床策略和商業性執行有機結合，在掌握新機會的同時降低系統性風險。首先，應優先考慮模組化產品藍圖，以便在無需徹底重新設計平台的情況下，對支架結構和塗層進行迭代改進。這可以降低開發風險，並透過逐步提升效能來加速臨床醫生對產品的接受度。同時，應投資進行對比臨床試驗和高品質的註冊研究，量化安全性和後續資源利用情況，從而為支付方和醫療保健系統提供更具吸引力的價值提案。

我們透明、多方面的調查方法，整合了臨床證據審查、相關人員訪談、供應鏈實質審查和情境分析，從而產生可操作的見解。

本調查方法整合了多種證據來源，確保假設和限制的透明度，並得出嚴謹且可重複的結論。首先，對同儕審查文獻、臨床試驗註冊庫和監管文件進行全面審查，以建立關於器械安全性、有效性和操作流程的基礎證據。在此案桌上研究調查方法的基礎上，輔以對臨床醫生、採購經理和品管負責人的定向訪談，以了解他們對器械性能、培訓需求和採購標準的實際觀點。

簡潔地總結了決定顱內支架領域成功的技術進步、臨床需求和商業性策略。

當前顱內支架市場呈現日益複雜的商業性格局，其背後是快速的技術創新、不斷發展的臨床實踐以及貿易政策和支付方的期望。材料生物學、支架幾何形狀和塗層技術的進步正在拓展介入神經放射學醫生可用的臨床工具，而成像技術和微導管平台的改進則拓寬了血管內治療的解剖學適用範圍。這些技術進步，加上對療效比較和成本透明度的日益成長的需求，正在重新定義商業性成功的標準。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 顱內支架市場：依產品類型分類

  • 球囊擴張型
  • 自膨脹
    • 編織
    • 雷射切割

第9章：顱內支架市場：依材料分類

  • 鈷鉻合金
  • 鎳鈦
  • 不銹鋼

第10章：顱內支架市場（依塗層分類）

  • 裸金屬
  • 藥物釋放型型
    • 紫杉醇
    • Sirolimus

第11章 顱內支架市場：依適應症分類

  • 動脈瘤
    • 紡錘形
    • 囊狀
  • 收縮
    • 動脈粥狀硬化
    • 血栓性

第12章 顱內支架市場：依最終用戶分類

  • 診所
  • 醫院

第13章 顱內支架市場：依通路分類

  • 直銷
    • 電子商務
    • 銷售團隊
  • 銷售代理
    • 全國銷售代理
    • 區域銷售代理

第14章 顱內支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 顱內支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 顱內支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國顱內支架市場

第18章：中國顱內支架市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH
  • B. Braun SE
  • Balt Extrusion SA
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra, Inc.
  • phenox GmbH
  • Shape Memory Therapeutics
  • Stryker Corporation
Product Code: MRR-43127F7279D7

The Intracranial Stents Market was valued at USD 1.03 billion in 2025 and is projected to grow to USD 1.19 billion in 2026, with a CAGR of 15.22%, reaching USD 2.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.03 billion
Estimated Year [2026] USD 1.19 billion
Forecast Year [2032] USD 2.80 billion
CAGR (%) 15.22%

A comprehensive introduction to intracranial stents that frames clinical needs, device evolution, regulatory context, and practical considerations for clinical adoption

Intracranial stents occupy a critical intersection between engineering innovation and acute neurovascular care, serving as essential tools in the treatment of both aneurysmal disease and intracranial stenosis. Over the past two decades, device designers and neurointerventionalists have refined stent architecture, materials, and deployment techniques to improve navigability through tortuous cerebral vasculature and to enhance long-term vessel remodeling. This evolution reflects a continuous dialogue between clinical feedback, imaging advances, and manufacturing capabilities, with each iteration seeking to minimize periprocedural risk while expanding the spectrum of treatable lesions.

Clinicians now face a complex decision matrix that weighs device profile, radial force, visibility under fluoroscopy, and compatibility with adjunctive devices. Concurrently, regulatory frameworks and payer expectations increasingly demand robust clinical evidence demonstrating durable outcomes and favorable safety profiles. As a result, development priorities have migrated beyond simple mechanical scaffolding toward integrated solutions that incorporate targeted drug delivery, novel alloys, and refined surface treatments. These trends are reshaping device development pipelines and altering adoption dynamics across procedural centers.

Understanding intracranial stents therefore requires a multi-faceted perspective that incorporates device-level science, clinical workflows, hospital procurement practices, and evolving reimbursement paradigms. For stakeholders seeking to align product strategy with clinical need, the imperative is to translate procedural insights and regulatory realities into commercially viable designs that demonstrably improve patient outcomes while fitting within health system procurement constraints.

Key transformative shifts in device engineering, clinical technique, and commercial approaches that are redefining intracranial stent development and adoption

The landscape for intracranial stents is undergoing transformative shifts driven by converging technological breakthroughs and changes in clinical practice. Material innovations, particularly advances in nickel-titanium alloys and cobalt-chromium processing, have enabled lower-profile devices that maintain radial strength while improving deliverability; simultaneously, refinements in laser-cut and braided architectures have expanded device selection to better match lesion morphology. These engineering advances are paralleled by the increasing incorporation of drug-eluting surface treatments designed to modulate neointimal proliferation and reduce restenosis risk, indicating a broader shift toward biologically active implantables.

Procedurally, the adoption of image-guided navigation and enhanced microcatheter platforms has expanded the reach of endovascular teams, enabling treatment of more distal and complex anatomies. This shift in capability has pressured manufacturers to optimize stent visibility, conformability, and compatibility with adjunct devices such as flow diverters and embolic coils. At the same time, healthcare systems are emphasizing value-based procurement, requiring demonstrable reductions in complication rates, procedure times, and downstream resource utilization. Consequently, product roadmaps and commercial strategies are aligning more tightly with measurable clinical and economic endpoints.

Finally, digital tools and direct-to-clinician channels are reshaping how training, post-market surveillance, and product iterations occur. Remote proctoring, digital libraries of procedural cases, and data-driven post-market registries are accelerating feedback loops between operators and developers, which in turn compresses the timeline from clinical insight to product refinement. Taken together, these shifts depict a market moving toward integrated, evidence-driven solutions that combine mechanical sophistication with biological and digital enhancements.

How 2025 tariff changes are reshaping supply chains, procurement behavior, regulatory planning, and commercial strategies across the intracranial stent ecosystem

The imposition of tariffs and trade policy adjustments in 2025 has introduced material complexities across global supply chains, with measurable downstream impacts on intracranial stent manufacturing, procurement, and pricing strategies. Manufacturers that rely on international supply networks for critical raw materials, precision alloy processing, or specialized contract manufacturing face higher landed costs and extended lead times. These pressures have compelled some stakeholders to reevaluate sourcing strategies, with many accelerating plans for nearshoring, dual-sourcing, and qualification of alternative suppliers to preserve production continuity and to manage input-cost volatility.

Procurement teams within hospitals and networks are experiencing heightened scrutiny as device price sensitivity grows alongside constrained capital allocations. Payers and health systems are increasingly requesting transparency on cost drivers and lifecycle economics, heightening the importance of demonstrating reductions in complication rates, readmissions, and total cost of care. As a result, manufacturers are responding by emphasizing value-based contracting, longer-term warranties, and bundled pricing models that align incentives and mitigate procurement risk.

Regulatory and clinical research timelines have also adapted in response to tariff-driven uncertainties. Sponsors engaged in international trials are reassessing supply plans and contingency provisions to ensure continuity of investigational device availability. Moreover, smaller innovators may feel disproportionate strain when tariffs increase component costs, prompting decisions to consolidate manufacturing, pursue licensing, or partner with larger incumbent firms. In sum, the cumulative effect of trade measures is to amplify the importance of supply chain resilience, commercial flexibility, and clear value articulation across the product lifecycle.

Actionable segmentation insights that align device architectures, material science, coating biology, indications, end-user needs, and distribution strategies into coherent commercialization pathways

Segmentation reveals where clinical needs, engineering innovations, and commercial strategies intersect to create differentiated value propositions. Based on product type, the market differentiates between balloon-expandable devices and self-expanding architectures; within the self-expanding category, braided and laser-cut designs present distinct performance trade-offs that influence clinical choice for complex anatomies. Balloon-expandable constructs remain relevant where precise deployment and vessel scaffolding are paramount, while self-expanding braided designs frequently offer superior conformability and flow-modifying characteristics in tortuous cerebral vessels.

Material selection is another primary axis of differentiation, with cobalt-chromium, nickel-titanium, and stainless steel each offering unique profiles in terms of radial strength, elasticity, and radiopacity. Nickel-titanium alloys are prized for superelasticity and shape memory, which support low-profile delivery and resilience against vessel recoil; cobalt-chromium provides high radial force in thin strut geometries; and stainless steel continues to serve as a cost-effective option for specific indications and manufacturing approaches.

Coating strategies further stratify product positioning. Bare metal designs appeal where long-term metal-host interactions are acceptable, whereas drug-eluting coatings are being explored to mitigate neointimal proliferation. Within drug-eluting approaches, paclitaxel and sirolimus-based formulations offer different biological mechanisms and release kinetics, shaping clinical trial designs and adoption patterns. Indication-based segmentation differentiates aneurysm treatment from stenosis management; aneurysm-focused devices must address both fusiform and saccular morphologies, requiring flexibility and, often, adjunctive flow diversion strategies, while stenosis interventions distinguish between atherosclerotic and thrombotic etiologies that drive distinct antiplatelet and procedural protocols.

End user and distribution channels round out the segmentation picture by shaping access and education pathways. Clinics and hospitals represent different procedural volumes and resource profiles, with high-volume tertiary centers often adopting cutting-edge devices earlier, and community hospitals favoring cost-effective, easy-to-deploy options. Distribution strategies that rely on direct sales can provide intensive clinical training through field force or digital engagement and can pair e-commerce channels for streamlined replenishment, whereas distributor networks-both national and regional-offer broader geographic reach and inventory management capabilities. Taken together, these segmentation layers guide product development, clinical evidence generation, and commercialization tactics that align device attributes with operator needs and procurement realities.

Regional intelligence describing how differences in clinical capacity, regulatory approach, and manufacturing ecosystems shape device adoption across the Americas, EMEA, and Asia-Pacific

Regional dynamics exert a powerful influence on the adoption, regulation, and manufacturing strategies for intracranial stents, and a nuanced appreciation of geographic differences is essential for effective planning. In the Americas, high concentrations of specialized neurovascular centers and mature reimbursement frameworks support early adoption of sophisticated device platforms, but procurement committees increasingly demand clear evidence of economic value that complements clinical performance. Consequently, companies aiming to grow in the Americas prioritize rigorous clinical data, post-market registries, and direct engagement with center-of-excellence networks to accelerate uptake and inform iterative product improvements.

The Europe, Middle East & Africa region presents a heterogeneous landscape in which regulatory pathways, reimbursement levels, and hospital capabilities vary widely. European regulatory convergence and strong clinical research ecosystems facilitate multi-center studies, while healthcare payors in many markets emphasize cost-effectiveness and comparative effectiveness research. In emerging markets across the Middle East and Africa, constrained procedural volumes and infrastructure limitations can slow adoption, yet there are significant opportunities to tailor lower-cost device variants and to invest in targeted training programs that expand capacity for neurointerventional procedures.

Asia-Pacific represents both a manufacturing hub and a rapidly evolving demand center, with several countries demonstrating accelerated adoption driven by growing neurosurgical capacity and expanding health system investment. Local manufacturing capabilities, availability of skilled interventionalists, and diverse reimbursement environments require strategies that balance global product standards with regional customization. Partnerships with regional distributors, local clinical leaders, and contract manufacturers can shorten time-to-market and optimize cost structures, while region-specific clinical evidence can bolster payer acceptance and clinician confidence. Across all regions, aligning regulatory strategy, clinical evidence programs, and supply chain planning to local realities remains a cornerstone of successful market entry and scaling.

Strategic company insights highlighting how incumbents, innovators, and suppliers are leveraging clinical data, manufacturing partnerships, and service models to secure competitive advantage

Key company behaviors reveal how market leaders and challengers are translating technical capabilities into competitive advantage. Established device manufacturers concentrate investments on iterative improvements to alloy processing, stent geometry, and delivery systems, while cultivating extensive clinical evidence through registries and randomized trials to underpin payer conversations. These firms often invest in global training networks and in-house field force capabilities to support high-complexity procedures and to secure long-term contracts with major health systems.

Smaller innovators and start-ups tend to specialize in disruptive materials, novel coating chemistries, or unique deployment mechanisms that address specific unmet clinical needs. Their pathways to scale typically involve building targeted clinical evidence, pursuing strategic partnerships with larger manufacturers for distribution and production, or seeking acquisition as an acceleration route. Contract manufacturers and component suppliers play a critical enabling role by offering precision machining, advanced finishing, and coating capabilities, thereby lowering the capital intensity required for device commercialization.

Across the competitive landscape, successful companies combine rigorous clinical programs with differentiated technical platforms and resilient supply chain strategies. Intellectual property portfolios, regulatory clearances in multiple jurisdictions, and the ability to demonstrate real-world clinical utility through registries and performance metrics are decisive factors that separate market leaders from the rest. Moreover, firms that integrate digital training, remote proctoring, and data-driven post-market surveillance are better positioned to shorten adoption cycles and to maintain clinician engagement over successive product generations.

Actionable recommendations for leaders to synchronize product roadmaps, supply chain resilience, clinical evidence, and hybrid commercial strategies to accelerate adoption

Industry leaders should pursue a coordinated agenda that aligns product development, clinical strategy, and commercial execution to capture emerging opportunities while mitigating systemic risks. First, prioritize modular product roadmaps that allow iterative improvements to stent architecture and coatings without requiring full platform redesigns; this reduces development risk and accelerates clinician adoption through incremental performance gains. Concurrently, invest in comparative clinical studies and high-quality registries that quantify both safety and downstream resource utilization, enabling stronger value propositions for payers and health systems.

Second, build supply chain resilience by diversifying suppliers for critical alloys and manufacturing steps, qualifying secondary production sites, and negotiating inventory and lead-time agreements that accommodate tariff-related disruptions. Consider strategic nearshoring or partnerships with regional contract manufacturers to reduce exposure to international trade volatility and to shorten replenishment cycles for key markets. Third, adopt hybrid go-to-market models that blend direct sales and digital engagement for high-volume centers with distributor partnerships that ensure geographic reach, leveraging e-commerce solutions for replenishment and service parts.

Finally, align commercialization with a robust clinician support program that includes hands-on training, remote mentoring, and outcomes dashboards to track real-world performance. Pair these initiatives with flexible commercial terms such as outcome-linked contracts or bundled offerings that share procedural and post-procedural risk with customers. By integrating these operational, clinical, and commercial actions, leaders can strengthen market positioning and accelerate sustainable adoption across diverse healthcare environments.

A transparent, multi-method research methodology integrating clinical evidence review, stakeholder interviews, supply chain diligence, and scenario analysis to produce actionable intelligence

The research approach synthesizes multiple evidence streams to produce rigorous, reproducible conclusions while ensuring transparency in assumptions and limitations. The methodology begins with a comprehensive review of peer-reviewed literature, clinical trial registries, and regulatory filings to assemble a foundational evidence base regarding device safety, efficacy, and procedural practices. This desk-based phase is complemented by targeted interviews with clinicians, procurement leaders, and quality officers to capture frontline perspectives on device performance, training needs, and purchasing criteria.

Supply chain mapping and technical due diligence were conducted through consultations with component suppliers, contract manufacturers, and materials experts to verify manufacturing constraints and to identify feasible mitigation strategies for tariff disruptions. The research also incorporated analyses of clinical registries and real-world datasets where available to corroborate trial findings and to observe longitudinal outcomes. Data triangulation occurred through cross-validation of interview insights, published studies, and regulatory documents to ensure that conclusions reflect convergent evidence rather than isolated anecdotes.

Throughout the process, scenario analysis was used to test the resilience of strategic options under different trade, reimbursement, and clinical-adoption assumptions. Limitations were explicitly documented, particularly where evidence was emerging or geographically variable, and recommendations were calibrated to reflect areas of high confidence versus those requiring additional primary research. This blended qualitative and quantitative approach produces actionable intelligence while preserving clarity about the strength and provenance of each insight.

A concise conclusion synthesizing the technical advances, clinical imperatives, and commercial actions that will determine success in the intracranial stent arena

The intracranial stent landscape is characterized by rapid technical innovation, shifting clinical practices, and an increasingly complex commercial context shaped by trade policy and payer expectations. Advances in materials, stent geometry, and coating biology are expanding the clinical toolkit available to neurointerventionalists, while improvements in imaging and microcatheter platforms are broadening the anatomical reach of endovascular therapy. These technical advances, coupled with heightened requirements for comparative outcomes and cost transparency, are redefining commercial success criteria.

Effective strategies will therefore blend rigorous clinical evidence generation with resilient manufacturing and distribution plans, and with commercial models aligned to purchaser priorities. Stakeholders that invest in durable clinical data, flexible supply chains, and clinician-centric training programs will be best positioned to convert technical advantages into widespread adoption. As the environment continues to evolve, ongoing monitoring of regulatory shifts, reimbursement changes, and supply chain signals will remain essential to maintain strategic agility and to seize timely opportunities for product differentiation and market growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intracranial Stents Market, by Product Type

  • 8.1. Balloon Expandable
  • 8.2. Self Expanding
    • 8.2.1. Braided
    • 8.2.2. Laser Cut

9. Intracranial Stents Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Nickel Titanium
  • 9.3. Stainless Steel

10. Intracranial Stents Market, by Coating

  • 10.1. Bare Metal
  • 10.2. Drug Eluting
    • 10.2.1. Paclitaxel
    • 10.2.2. Sirolimus

11. Intracranial Stents Market, by Indication

  • 11.1. Aneurysm
    • 11.1.1. Fusiform
    • 11.1.2. Saccular
  • 11.2. Stenosis
    • 11.2.1. Atherosclerotic
    • 11.2.2. Thrombotic

12. Intracranial Stents Market, by End User

  • 12.1. Clinics
  • 12.2. Hospitals

13. Intracranial Stents Market, by Distribution Channel

  • 13.1. Direct Sales
    • 13.1.1. E Commerce
    • 13.1.2. Field Force
  • 13.2. Distributor
    • 13.2.1. National Distributors
    • 13.2.2. Regional Distributors

14. Intracranial Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intracranial Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intracranial Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Intracranial Stents Market

18. China Intracranial Stents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Acandis GmbH
  • 19.7. B. Braun SE
  • 19.8. Balt Extrusion S.A.
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardinal Health, Inc.
  • 19.11. Cook Group Incorporated
  • 19.12. Integer Holdings Corporation
  • 19.13. Johnson & Johnson
  • 19.14. Medtronic plc
  • 19.15. Merit Medical Systems, Inc.
  • 19.16. MicroVention, Inc.
  • 19.17. Penumbra, Inc.
  • 19.18. phenox GmbH
  • 19.19. Shape Memory Therapeutics
  • 19.20. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRACRANIAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRACRANIAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY LASER CUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY LASER CUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY LASER CUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NICKEL TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NICKEL TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NICKEL TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PACLITAXEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PACLITAXEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SIROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SIROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SACCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SACCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY SACCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ATHEROSCLEROTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ATHEROSCLEROTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY ATHEROSCLEROTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY THROMBOTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY THROMBOTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY THROMBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FIELD FORCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FIELD FORCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY FIELD FORCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 208. GCC INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 211. GCC INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 213. GCC INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 214. GCC INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 216. GCC INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GCC INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 247. G7 INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 250. G7 INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 252. G7 INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 253. G7 INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 255. G7 INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. G7 INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. G7 INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 260. NATO INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 263. NATO INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 265. NATO INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 266. NATO INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 267. NATO INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 268. NATO INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. NATO INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 272. NATO INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA INTRACRANIAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2018-2032 (USD MILLION)